RT Journal Article
SR Electronic
T1 Predicting the COVID-19 epidemic in Algeria using the SIR model
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.25.20079467
DO 10.1101/2020.04.25.20079467
A1 Boudrioua, Mohamed Samir
A1 Boudrioua, Abderrahmane
YR 2021
UL http://medrxiv.org/content/early/2021/01/06/2020.04.25.20079467.abstract
AB The aim of this study is to predict the daily infected cases with Coronavirus (COVID-19) in Algeria. We apply the SIR model on data from 25 February 2020 to 24 April 2020 for the prediction. Following Huang et al (12), we develop two SIR models, an optimal model and a model in a worst-case scenario COVID-19. We estimate the parameters of our models by minimizing the negative log likelihood function using the Nelder-Mead method. Based on the simulation of the two models, the epidemic peak of COVID-19 is predicted to attain 24 July 2020 in a worst-case scenario, and the COVID-19 disease is expected to disappear in the period between September 2020 and November 2020 at the latest. We suggest that Algerian authorities need to implement a strict containment strategy over a long period to successfully decrease the epidemic size, as soon as possible.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNoneFunding StatementThe authors received no specific funding for this workAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NoneAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are obtained from: https://github.com/CSSEGISandData/COVID-19/tree/master/csse_covid_19_data/csse_covid_19_time_series https://github.com/CSSEGISandData/COVID-19/tree/master/csse_covid_19_data/csse_covid_19_time_series